TY - JOUR T1 - Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic JF - medRxiv DO - 10.1101/2020.04.08.20056861 SP - 2020.04.08.20056861 AU - Flavia Riccardo AU - Marco Ajelli AU - Xanthi D Andrianou AU - Antonino Bella AU - Martina Del Manso AU - Massimo Fabiani AU - Stefania Bellino AU - Stefano Boros AU - Alberto Mateo Urdiales AU - Valentina Marziano AU - Maria Cristina Rota AU - Antonietta Filia AU - Fortunato Paolo D’Ancona AU - Andrea Siddu AU - Ornella Punzo AU - Filippo Trentini AU - Giorgio Guzzetta AU - Piero Poletti AU - Paola Stefanelli AU - Maria Rita Castrucci AU - Alessandra Ciervo AU - Corrado Di Benedetto AU - Marco Tallon AU - Andrea Piccioli AU - Silvio Brusaferro AU - Giovanni Rezza AU - Stefano Merler AU - Patrizio Pezzotti AU - for the COVID-19 working group Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/11/2020.04.08.20056861.abstract N2 - Background In February 2020, a locally-acquired COVID-19 case was detected in Lombardia, Italy. This was the first signal of ongoing transmission of SARS-CoV-2 in the country. The outbreak rapidly escalated to a national level epidemic, amid the WHO declaration of a pandemic.Methods We analysed data from the national case-based integrated surveillance system of all RT-PCR confirmed COVID-19 infections as of March 24th 2020, collected from all Italian regions and autonomous provinces. Here we provide a descriptive epidemiological summary on the first 62,843 COVID-19 cases in Italy as well as estimates of the basic and net reproductive numbers by region.Findings Of the 62,843 cases of COVID-19 analysed, 71.6% were reported from three Regions (Lombardia, Veneto and Emilia-Romagna). All cases reported after February 20th were locally acquired. Estimates of R0 varied between 2.5 (95%CI: 2.18-2.83) in Toscana and 3 (95%CI: 2.68-3.33) in Lazio, with epidemic doubling time of 3.2 days (95%CI: 2.3-5.2) and 2.9 days (95%CI: 2.2-4.3), respectively. The net reproduction number showed a decreasing trend starting around February 20-25, 2020 in Northern regions. Notably, 5,760 cases were reported among health care workers. Of the 5,541 reported COVID-19 associated deaths, 49% occurred in people aged 80 years or above with an overall crude CFR of 8.8%. Male sex and age were independent risk factors for COVID-19 death.Interpretation The COVID-19 infection in Italy emerged with a clustering onset similar to the one described in Wuhan, China and likewise showed worse outcomes in older males with comorbidities. Initial R0 at 2.96 in Lombardia, explains the high case-load and rapid geographical spread observed. Overall Rt in Italian regions is currently decreasing albeit with large diversities across the country, supporting the importance of combined non-pharmacological control measures.Funding routine institutional funding was used to perform this work.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRoutine institutional funding was used to perform this workAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are collected through the national integrated surveillance system for COVID-19 in Italy ER -